By Drug Target Review2024-05-08T15:00:42
Researchers showed that ESI1, or similar compounds, may help to slow or even reverse cognitive losses that can occur during aging.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-03-11T14:00:00
Sponsored by Merck
2025-05-14T14:30:00
Sponsored by Abzena
2024-02-01T11:52:50
Sponsored by Leica Microsystems
2023-11-24T12:06:45
Sponsored by Quantum-Si
2023-06-20T12:34:32
Sponsored by NanoTemper Technologies
2023-07-04T10:05:58
Sponsored by Revvity
Site powered by Webvision Cloud